EditCo Bio
Pete Dansky is an experienced leader in the life sciences and biotechnology sectors, currently serving as a Board Member at EditCo Bio and a Senior Advisor at Telegraph Hill Partners. Previously, Dansky held the position of Chief Executive Officer and Board Member at Agena Bioscience, overseeing innovative systems for nucleic acid detection and diagnostic applications. Additional board roles include Verogen, the first sequencing company dedicated to forensic science, as well as an executive focus on enhancing molecular biology research at Life Technologies, where Dansky progressed through various leadership roles, including President of multiple divisions. An academic background includes an MBA from Boston College and a dual degree in Chemical Engineering from Tufts University.
This person is not in the org chart
This person is not in any teams
EditCo Bio
Whatever your edit, we can make it easier with optimized, multi-guide CRISPR kits and made-to-order edited cells. We're dedicated to building a novel research toolkit to make genome engineering simpler and more efficient. EditCo's CRISPR expertise and highly automated manufacturing allows us to engineer a wide variety of cell lines with the speed, consistency, and functionality than can redefine research. Leave CRISPR to us–you focus on discoveries.